comparemela.com

Latest Breaking News On - Holdingsas novo - Page 1 : comparemela.com

Spruce Biosciences, Inc (NASDAQ:SPRB) Shares Purchased by AIGH Capital Management LLC

AIGH Capital Management LLC grew its holdings in shares of Spruce Biosciences, Inc. (NASDAQ:SPRB – Free Report) by 75.4% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 2,123,863 shares of the company’s stock after acquiring an additional 912,863 shares during the period. […]

Spruce Biosciences, Inc (NASDAQ:SPRB) Given Consensus Rating of Hold by Analysts

Spruce Biosciences, Inc. (NASDAQ:SPRB – Get Free Report) has been assigned a consensus rating of “Hold” from the eight ratings firms that are currently covering the stock, MarketBeat reports. Six research analysts have rated the stock with a hold rating and two have given a buy rating to the company. The average 1-year target price […]

HC Wainwright Raises IO Biotech (NASDAQ:IOBT) Price Target to $12 00

IO Biotech (NASDAQ:IOBT – Free Report) had its price objective increased by HC Wainwright from $8.00 to $12.00 in a research report released on Wednesday morning, Benzinga reports. They currently have a buy rating on the stock. HC Wainwright also issued estimates for IO Biotech’s Q2 2024 earnings at ($0.31) EPS, Q3 2024 earnings at […]

IO Biotech (NASDAQ:IOBT) Price Target Raised to $12 00 at HC Wainwright

IO Biotech (NASDAQ:IOBT) Price Target Raised to $12 00 at HC Wainwright
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

JPMorgan Chase & Co Lowers Metagenomi (NASDAQ:MGX) to Neutral

JPMorgan Chase & Co. lowered shares of Metagenomi (NASDAQ:MGX – Free Report) from an overweight rating to a neutral rating in a report published on Thursday, MarketBeat.com reports. They currently have $6.00 target price on the stock, down from their prior target price of $16.00. A number of other equities research analysts have also issued […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.